- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15:14 | Optimind Pharma Corp.: Optimind Pharma Announces Adoption of Semi-Annual Reporting | 221 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 24, 2026) - Optimind Pharma Corp. (CSE: OMND) ("Optimind" or the "Company") announces that it has elected to voluntarily adopt semi-annual financial reporting... ► Artikel lesen | |
| 11.09.25 | CSE Bulletin: Halted for Fundamental Change - Optimind Pharma Corp. (OMND) | 393 | Newsfile | Toronto, Ontario--(Newsfile Corp. - Le 11 septembre/September 2025) - Trading in the shares of Optimind Pharma Corp. (OMND) will remain halted pending receipt and review of acceptable documentation... ► Artikel lesen | |
| 08.09.25 | Optimind Pharma Corp.: Optimind Pharma Announces Definitive Agreement for Proposed Change of Business with InterviewDesk | 576 | Newsfile | Toronto, Ontario--(Newsfile Corp. - September 8, 2025) - Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") is pleased to announce that it has entered into a binding definitive share... ► Artikel lesen | |
| OPTIMIND PHARMA Aktie jetzt für 0€ handeln | |||||
| 04.09.25 | Optimind Pharma Corp.: Optimind Pharma Announces Termination of Letter of Intent | 654 | Newsfile | Toronto, Ontario--(Newsfile Corp. - September 4, 2025) - Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") announces that its previously announced non-binding letter of intent dated... ► Artikel lesen |
4 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 43,155 | +1,91 % | Novo Nordisk meldet sich im Abnehmduell zurück | Im globalen Geschäft mit Abnehmmedikamenten verschiebt sich der Wettbewerb erneut. Novo Nordisk hat für die Wegovy-Tablette die Zulassung in der Europäischen Union erhalten und kann damit früher als... ► Artikel lesen | |
| AURORA CANNABIS | 2,336 | -1,02 % | Aurora Cannabis Inc (3): Aurora Cannabis's Safari receives EU-GMP certification | ||
| CANOPY GROWTH | 0,780 | -1,66 % | Stocks in Play: Canopy Growth Corporation | ||
| BIOTEST | 33,000 | 0,00 % | Osborne Clarke berät Grifols S.A. bei der Umwandlung der Biotest AG in eine GmbH & Co. KGaA | ||
| DIGICANN VENTURES | 0,002 | -91,43 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| SINOPHARM | 1,851 | -1,39 % | Dividendenbekanntmachungen (23.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADAMAS TRUST INC US6496048405 0,27 USD 0,2362 EUR AECON GROUP INC CA00762V1094 0,1925 CAD 0,1189 EUR AMPHENOL CORPORATION US0320951017 0... ► Artikel lesen | |
| CSPC PHARMA | 0,943 | +1,43 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - PALIPERIDONE PALMITATE INJECTION RECEIVES MARKETING APPROVAL | ||
| TONIX PHARMACEUTICALS | 9,000 | -3,62 % | Tonix Pharmaceuticals Holding Corp. - 8-K, Current Report | ||
| AXSOME THERAPEUTICS | 214,80 | +1,08 % | Axsome Therapeutics, Inc.: Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-12 for the Treatment of Cataplexy in Narcolepsy | FDA sets PDUFA target action date of May 1, 2027 NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment... ► Artikel lesen | |
| ORAMED PHARMACEUTICALS | 3,695 | +0,96 % | Oramed Pharmaceuticals Inc.: Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet | Significant Appreciation in Alpha Tau (NASDAQ: DRTS) Position (up ~$128 Million)
Scilex (NASDAQ: SCLX) Loan Substantially Repaid
Total Cash and Assets Build... ► Artikel lesen | |
| ADASTRA | 0,115 | -100,00 % | CSE Bulletin: Suspensions - Adastra Holdings Ltd., CAT Strategic Metals Corporation, Greenrise Global Brands Inc., StickIt Technologies Inc. | Le 12 mai/May 2026
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101... ► Artikel lesen | |
| ACHIEVE LIFE SCIENCES | 5,350 | -1,83 % | Achieve Life Sciences Joins Russell 2000 Index | SEATTLE and VANCOUVER, British Columbia, June 29, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 10,200 | -5,99 % | Sellas Life (SLS) Climbs 12% Ahead of 'Potentially Company-Defining' Clinical Trial Result | ||
| ALTIMMUNE | 2,565 | +3,01 % | Altimmune, Inc: Altimmune Announces First Quarter 2026 Financial Results and Business Update | Initiation of PERFORMA Phase 3 MASH trial planned for second half 2026 $535 million in cash, cash equivalents and short-term investments as of April 30, 2026 Webcast to be held today at 8:30 a.m.... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 27,300 | +2,63 % | Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals | The Italian pharma company grows its presence in the U.S. market and strengthens its global leadership in Brain Health and Rare DiseasesCompletion of the transaction gives Angelini Pharma ownership... ► Artikel lesen |
Das Unternehmen OPTIMIND PHARMA CORP kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu OPTIMIND PHARMA CORP finden Sie auf Wallstreet Online.